Literature DB >> 3937084

Ocular histopathology of systemic mucopolysaccharidosis, type II-A (Hunter syndrome, severe).

J M McDonnell, W R Green, I H Maumenee.   

Abstract

A case of mucopolysaccharidosis, Type II-A (Hunter syndrome, severe) is described, with emphasis on ocular ultrastructural findings. Single membrane-bound structures containing fibrillogranular and, less commonly, multi-membranous material were found in conjunctival epithelium, pericytes and fibrocytes; corneal epithelium, keratocytes, and endothelium; trabecular endothelium; iris pigmented epithelium, smooth muscle, and fibrocytes; ciliary pigmented and nonpigmented epithelium and fibrocytes; retinal pigment epithelium and ganglion cells; optic nerve astrocytes and pericytes; and sclerocytes. The most striking accumulation was in the nonpigmented ciliary epithelium. These findings are compared with those seen in MPS II-B, and in other systemic mucopolysaccharidoses. The nature and distribution of inclusions are not specific to any one disorder, but help to signal the presence of one of the storage disorders. Distension of corneal keratocytes may play a role in the corneal clouding seen in some of these disorders. The importance of tissue examination, especially conjunctival biopsy, in the diagnosis of storage disorders and in assessment of future modes of therapy for the mucopolysaccharidoses is discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3937084     DOI: 10.1016/s0161-6420(85)34107-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Early Retinal Changes in Hunter Syndrome According to Spectral Domain Optical Coherence Tomography.

Authors:  Seonghwan Kim; Yung Ju Yoo; Se Joon Woo; Hee Kyung Yang
Journal:  Korean J Ophthalmol       Date:  2016-03-25

2.  Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase.

Authors:  Michel C Tchan; Kerry T Devine; David O Sillence
Journal:  JIMD Rep       Date:  2011-06-22

3.  Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A).

Authors:  M Iwamoto; Y Nawa; I H Maumenee; J Young-Ramsaran; R Matalon; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A.

Authors:  Susie Seok; In Jeong Lyu; Kyung Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-18       Impact factor: 3.117

5.  High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome.

Authors:  Michael K Yoon; Royce W Chen; Thomas R Hedges; Vivek J Srinivasan; Iwona Gorczynska; James G Fujimoto; Maciej Wojtkowski; Joel S Schuman; Jay S Duker
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Sep-Oct

6.  Recovery of Vision following Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II, Hunter Syndrome.

Authors:  Ryutaro Yamanishi; Natsuko Nakamura; Kazushige Tsunoda
Journal:  Case Rep Ophthalmol       Date:  2019-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.